Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy

Heart, Artery and Coronary DiseasesTherapy and Intervention

Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients

Clin Res Cardiol

Kirchner J, Gerçek M, Sciacca V, Reil JC, Guckel D, Potratz M, Omran H, Friedrichs K, Eitz T, Bleiziffer S, Schramm R, Imnadze G, Sohns C, Gummert J, Rudolph V, Rudolph TK, Sommer P, Fink T

doi: 10.1007/s00392-024-02450-1

Heart Failure

Cardiac resynchronization therapy in acute heart failure and left bundle-branch block in a real-life registry

Colomb Med (Cali)

Aguiló O, Trullàs JC, Espinosa B, López-Ayala P, Gil V, López-Grima ML, Herrero-Puente P, Jacob J, López-Díez MP, Garrido JM, Millán J, Aguirre A, Piñera P, Müller CE, Llorens P, Miro Ò

doi: 10.25100/cm.v54i4.5850

Heart Failure

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

ESC Heart Fail

García-Bolao I, Gardner RS, Gras D, D'Onofrio A, Mark G, Nair D, Lellouche N, Novak M, Lo R, Chew E, Wright D, Kaplan A, Bertini M, Veraghtert S, Harbin MM, Matznick E, Yong P, Stein KM

doi: 10.1002/ehf2.15190

Heart Failure

Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure

J Am Heart Assoc

Gentile F, Chianca M, Bazan L, Sciarrone P, Chubuchny V, Taddei C, Poggianti E, Passino C, Emdin M, Giannoni A

doi: 10.1161/JAHA.124.038616

Further Publications

Mechanical dyssynchrony as a selection criterion for cardiac resynchronization therapy: Design of the AMEND-CRT trial

ESC Heart Fail

Puvrez A, Duchenne J, Donal E, Gorcsan J 3rd, Patel HC, Marwick TH, Smiseth OA, Søgaard P, Stankovic I, Diogo PG, Vörös G, Voigt JU

doi: 10.1002/ehf2.14932

Heart, Artery and Coronary Diseases

Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy

Heart

Maurizi N, Nowak A, Gruner C, Namdar M, Schmied C, Porretta AP, Barbey G, Monzambani V, Monney P, Barbey F

doi: 10.1136/heartjnl-2024-323975

Heart, Artery and Coronary DiseasesVentricular Function

Recovery of Left Ventricular Function and Long-Term Outcomes in Patients With Takotsubo Syndrome

J Am Coll Cardiol

Almendro-Delia M, López-Flores L, Uribarri A, Vedia O, Blanco-Ponce E, López-Flores MDC, Rivas-García AP, Fernández-Cordón C, Sionis A, Martín-García AC, Vazirani R, Corbí-Pascual M, Salamanca J, Pérez-Castellanos A, Martínez M, Becerra VM, Aritza-Conty D, López-País J, Guillén-Marzo M, Lluch-Requerey C, García-Rubira JC, Núñez-Gil IJ, RETAKO Investigators

doi: 10.1016/j.jacc.2024.05.075

Heart, Artery and Coronary Diseases

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

J Am Heart Assoc

Shivakumar N, Friedman DJ, Fudim M, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Young J, Tang A, Olivas-Martinez A, Inoue LYT, Sanders GD, Al-Khatib SM

doi: 10.1161/JAHA.123.031785

Heart Failure

Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: advancing patient selection?

Heart Rhythm

Trenson S, Kahr PC, Schwaiger JM, Betschart P, Kuster J, Vandenberk B, Duchenne J, Beela AS, Stankovic I, Voros G, Flammer AJ, Schindler M, Saguner AM, Willems R, Ruschitzka F, Steffel J, Breitenstein A, Voigt JU, Winnik S

doi: 10.1016/j.hrthm.2024.10.031

Related content

Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients

Cardiac resynchronization therapy in acute heart failure and left bundle-branch block in a real-life registry

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure

Mechanical dyssynchrony as a selection criterion for cardiac resynchronization therapy: Design of the AMEND-CRT trial

Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy

Recovery of Left Ventricular Function and Long-Term Outcomes in Patients With Takotsubo Syndrome

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: advancing patient selection?